Your browser doesn't support javascript.
loading
Long-term follow-up of lenalidomide and rituximab as initial treatment of follicular lymphoma.
Strati, Paolo; Jain, Preetesh; Johnson, Ralph J; Forbes, Sheryl; Feng, Lei; Samaniego, Felipe; Rodriguez, Maria A; Fayad, Luis E; Hagemeister, Fredrick; Westin, Jason; Wang, Michael; Neelapu, Sattva S; Nastoupil, Loretta J; Fowler, Nathan H.
Afiliación
  • Strati P; Department of Lymphoma and Myeloma and.
  • Jain P; Department of Lymphoma and Myeloma and.
  • Johnson RJ; Department of Lymphoma and Myeloma and.
  • Forbes S; Department of Lymphoma and Myeloma and.
  • Feng L; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Samaniego F; Department of Lymphoma and Myeloma and.
  • Rodriguez MA; Department of Lymphoma and Myeloma and.
  • Fayad LE; Department of Lymphoma and Myeloma and.
  • Hagemeister F; Department of Lymphoma and Myeloma and.
  • Westin J; Department of Lymphoma and Myeloma and.
  • Wang M; Department of Lymphoma and Myeloma and.
  • Neelapu SS; Department of Lymphoma and Myeloma and.
  • Nastoupil LJ; Department of Lymphoma and Myeloma and.
  • Fowler NH; Department of Lymphoma and Myeloma and.
Blood ; 137(8): 1124-1129, 2021 02 25.
Article en En | MEDLINE | ID: mdl-32932518

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Linfoma Folicular / Rituximab / Lenalidomida / Antineoplásicos Tipo de estudio: Observational_studies / Prognostic_studies Idioma: En Revista: Blood Año: 2021 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Linfoma Folicular / Rituximab / Lenalidomida / Antineoplásicos Tipo de estudio: Observational_studies / Prognostic_studies Idioma: En Revista: Blood Año: 2021 Tipo del documento: Article